Melanoma, Secondary cancers, Skin cancer
Results
Phase 3
This trial compared 2 drugs called encorafenib and binimetinib with vemurafenib for melanoma skin cancer.
This trial was for people with melanoma skin cancer that had spread to nearby or to another part of the body (advanced melanoma). And whose melanoma cells had a change in the gene called BRAF.
Recruitment start: 12 September 2013
Recruitment end: 11 January 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Middleton
Array Biopharma Inc
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 16 January 2019
CRUK internal database number: 11136
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
